In the rapidly evolving Medtech industry, staying on top of growth strategies, including mergers and acquisitions (M&A)–related deal activity, is not just an advantage—it’s a necessity.
For one leading MedTech company, Avanos Medical, the challenge was clear: streamline its corporate development and strategy workflows to drive innovation and maintain a competitive edge. The obstacle? A fragmented approach to market intelligence that slowed down decision making and obscured valuable insights.
Avanos’s strategy team needed comprehensive, timely…
